96 related articles for article (PubMed ID: 9384688)
1. AK-5 tumor-induced modulation of host immune function: upregulation of Th-1-type cytokine response mediates early tumor regression.
Khar A; Kausalya S; Kamal MA
Cytokines Mol Ther; 1996 Mar; 2(1):39-46. PubMed ID: 9384688
[TBL] [Abstract][Full Text] [Related]
2. Early expression of interleukin-12, p40 subunit and IFN-gamma inhibits regression of AK-5 tumor.
Nandakumar KS; Kumari AL; Khar A
Cytokines Cell Mol Ther; 1997 Dec; 3(4):225-32. PubMed ID: 9740351
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of antitumor immunity by IL-12 gene-transfected AK-5 tumor cells in vivo.
Nandakumar KS; Lakshmi Rao K; Pardhasaradhi BV; Khar A
Cytokines Cell Mol Ther; 1999 Mar; 5(1):7-14. PubMed ID: 10390075
[TBL] [Abstract][Full Text] [Related]
4. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
Muralikrishna K; Varalakshmi C; Khar A
Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
[TBL] [Abstract][Full Text] [Related]
5. Role of cytokines in the maintenance of the memory immune response induced by a rat histiocytoma in syngeneic hosts.
Nandakumar KS; Varalakshmi C; Khar A
Cytokines Cell Mol Ther; 1998 Sep; 4(3):169-75. PubMed ID: 9825842
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cell activation-associated induction of target cell DNA fragmentation in a spontaneously regressing rat histiocytoma.
Bright JJ; Kausalya S; Khar A
Immunology; 1995 Aug; 85(4):638-44. PubMed ID: 7558160
[TBL] [Abstract][Full Text] [Related]
7. AK-5 tumor-induced expression of interleukin-12: role of IL-12 in NK-mediated AK-5 regression.
Hegde SP; Bright JJ; Kausalya S; Khar A
Cell Immunol; 1995 May; 162(2):241-7. PubMed ID: 7743551
[TBL] [Abstract][Full Text] [Related]
8. Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).
Itoh K; Shiiba K; Shimizu Y; Suzuki R; Kumagai K
J Immunol; 1985 May; 134(5):3124-9. PubMed ID: 2984283
[TBL] [Abstract][Full Text] [Related]
9. Administration of anti-IL-12 antibody in vivo inhibits rejection of a rat histiocytoma and suppresses cytokine response in a tumour-bearing host.
Rao KL; Varalakshmi C; Ali AM; Khar A
Immunology; 1997 Nov; 92(3):381-7. PubMed ID: 9486112
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells.
Grohmann U; Silla S; Belladonna ML; Bianchi R; Orabona C; Puccetti P; Fioretti MC
Cell Immunol; 1997 Nov; 181(2):109-19. PubMed ID: 9398398
[TBL] [Abstract][Full Text] [Related]
11. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.
Fehniger TA; Shah MH; Turner MJ; VanDeusen JB; Whitman SP; Cooper MA; Suzuki K; Wechser M; Goodsaid F; Caligiuri MA
J Immunol; 1999 Apr; 162(8):4511-20. PubMed ID: 10201989
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of antibody-dependent natural killer cell-mediated AK-5 tumor cell death.
Kausalya S; Hegde SP; Bright JJ; Khar A
Exp Cell Res; 1994 Jun; 212(2):285-90. PubMed ID: 8187821
[TBL] [Abstract][Full Text] [Related]
13. [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL; AntĂșnez MI; Abrami AA
Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
[TBL] [Abstract][Full Text] [Related]
14. IL-18-induced expression of intercellular adhesion molecule-1 in human monocytes: involvement in IL-12 and IFN-gamma production in PBMC.
Yoshida A; Takahashi HK; Nishibori M; Iwagaki H; Yoshino T; Morichika T; Yokoyama M; Kondo E; Akagi T; Tanaka N
Cell Immunol; 2001 Jun; 210(2):106-15. PubMed ID: 11520077
[TBL] [Abstract][Full Text] [Related]
15. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.
Wei H; Zheng X; Lou D; Zhang L; Zhang R; Sun R; Tian Z
Mol Immunol; 2005 May; 42(9):1023-31. PubMed ID: 15829292
[TBL] [Abstract][Full Text] [Related]
16. Th1 cytokines and NK cells participate in the development of murine syngeneic graft-versus-host disease.
Flanagan DL; Jennings CD; Bryson JS
J Immunol; 1999 Aug; 163(3):1170-7. PubMed ID: 10415011
[TBL] [Abstract][Full Text] [Related]
17. Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration.
Plain KM; Boyd R; Verma ND; Robinson CM; Tran GT; Hodgkinson SJ; Hall BM
Transplantation; 2007 Mar; 83(6):764-73. PubMed ID: 17414711
[TBL] [Abstract][Full Text] [Related]
18. In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer.
Nagai H; Horikawa T; Hara I; Fukunaga A; Oniki S; Oka M; Nishigori C; Ichihashi M
Exp Dermatol; 2004 Oct; 13(10):613-20. PubMed ID: 15447721
[TBL] [Abstract][Full Text] [Related]
19. Combinations of the cytokines IL-12, IL-2 and IFN-alpha significantly augment whereas the cytokine IL-4 suppresses the cytokine-induced antibody-dependent cellular cytotoxicity of monoclonal antibodies 17-1A and BR55-2.
Flieger D; Spengler U; Beier I; Sauerbruch T; Schmidt-Wolf I
Cytokine; 2000 Jun; 12(6):756-61. PubMed ID: 10843759
[TBL] [Abstract][Full Text] [Related]
20. Cellular mechanisms of interleukin-12-mediated neuroblastoma regression.
Redlinger RE; Shimizu T; Remy T; Alber S; Watkins SC; Barksdale EM
J Pediatr Surg; 2003 Feb; 38(2):199-204. PubMed ID: 12596103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]